Carl Accettura is the Vice President & General Manager for PharmoRx Therapeutics, Inc., engaged in early stage development of novel therapy for the central nervous system, including Treatment Resistant Depression and Parkinson’s Disease. Carl has 30 years of BioPharma industry experience with both Big Pharma - Pfizer, Roche, BMS – and Emergent Pharma companies - Anesta, Cephalon, Kyowa Hakko Kirin, Dainippon Sumitomo Pharma, Sunovion, and Braeburn Pharmaceuticals. Carl has held executive level (VP) positions in the areas of supply chain, new product development and operations. He has overseen the development of end-to-end supply chain strategies, operations, and product launches across the US, Europe and Asia. Carl successfully launched major branded drugs (Procardia XL, Diflucan, Norvasc, Zithromax, Zoloft, Cardura, Actiq and Latuda) globally. He did this by ensuring advanced commercial readiness through effective global and regional regulatory filings and approvals. He founded a consulting firm, Global Pharma Consulting, which was established to support small and medium-sized companies commercialize Rx products. Carl’s most recent role was Vice President, Supply Chain at Braeburn Pharmaceuticals, where he developed the virtual supply chain for commercial launch readiness of a novel opioid implant product. He championed a novel trace and trace solution with partner, Covectra, for Probuphine’s strategic positioning as the “safest in the market”. He now supports Track & Trace solutions in the Life Sciences for Covectra. Carl’s subject matter expertise in pharmaceutical new product launch and supply chain management makes him a sought after speaker.      He speaks each semester at the Cornell University Enterprise Engineering Seminar. Carl earned a B.S. with distinction from Cornell University in Mechanical Engineering. He also holds a M.S. from University of Illinois and a M.B.A from the Stern School at New York University. 

Nish Chudasama is currently Group Leader Clinical Supply Chain Operations at Bristol-Myers Squibb. In this role he oversees end-to-end supply chain operations from Drug Substance and Drug Product Manufacturing to Packaging & Labeling for Clinical Supplies.

Nish has over 15 years of experience in the pharmaceutical industry, spanning various dimensions of the supply chain including Temperature Controlled Logistics, Operations Management and Customer Service. Over the course of his career Nish has supported the supply chains of several large organizations including Bristol-Myers Squibb, Novo Nordisk, Sanofi Aventis, Samsung and P&G.

Nish holds an MBA in Supply Chain from Syracuse University and an Executive Certificate in Technology, Operations & Value Chain Management from MIT.

Marcelo has 20 years experience in the health care and consumer/ high tech industry with Bristol-Myers Squibb and other Fortune 500 companies. He has held management positions in the areas of logistics, operations management, supply chain planning, customer service and international trade both in South and North America. His current role at BMS is Regional Director, Global Logistics Services responsible for distribution strategy, logistics compliance, 3PL management, best practices implementation and customer service.

John Danese has built his reputation as a global pharmaceutical manufacturing and supply chain expert, bringing new capabilities and products to market to address industry-specific needs. A good communicator, John is intrinsically helpful and motivates people to work together efficiently and effectively as a team. His domain knowledge and comprehensive understanding of the Life Sciences industry across technologies and business processes help him in smoothly handling complex customer projects. 

George Donato is the Vice President, Global Supply Operations for Iroko Pharmaceuticals based in Philadelphia, PA for the past 4 years.  He leads a virtual external global supply network consisting of API & bulk manufacturing, packaging and global distribution center.  Iroko Pharmaceuticals recently launch three new sub-micron NSAID products from this new external supply organization.  George also spent over twelve years at Pfizer in Collegeville, PA, initially in Global Supply Chain, New Product Launch Leadership and External Supply Management.   He graduated from Widener University and earned a MBA and a BS in Engineering.

Stephen Gotthardt has been with Boehringer Ingelheim since 1999. In his current position, he is Corporate Vice President Supply Chain & Key Account Management and is based in Germany. Since 2000, Stephan has been a key member and chairperson of Boehringer Ingelheim’s worldwide supply chain organization and of its Global Supply Chain Conferences.

Stephan will be opening the Segmentation Master Class Workshop at our Pre-Conference Summit on Monday 7th April, as well as hosting his own roundtable, Talent management: build a training scheme & up-skill staff on a global scale, at 17.00 at the end of Main Conference Day One, Tuesday 8th April.

Michele has over 20 years of experience in the pharmaceutical industry during which 15 years have been focused on supply chain management. Currently she is at Sandoz where she is the Director, Supplier Relationship Management. She has responsibilities for both program management and supplier relationships. Prior to Sandoz, Michele was an industry consultant utilizing her expertise in supply chain and project management. During her consulting days, she also became a leader in the management of temperature sensitive products. Michele started her career with Merck. During her tenure at Merck, she was Executive Director, New Products Management, where she led a group of experienced professionals in the management and execution of new product supply chains supporting launches of products world-wide.

Peter oversees the entire global clinical trial supply chain for more than 500 studies in over 100 countries for Ancillare, LP. 

Peter is an experienced executive in global end-to-end supply chain management and has worked in all aspects of the supply chain from raw materials to disposal and destruction.  Prior to Ancillare, Peter held supply chain executive leadership roles in the USA, Asia, Latin America and Europe for DHL, XPO Logistics, APL Logistics and The Linde Group.  Peter’s “on the ground” experiences in all continents of the world have been instrumental in his leadership of global expansion efforts at Ancillare. He has successfully identified and launched Ancillare depots in more than 15 regions throughout the world including Latin America, Russia/Ukraine, China and Japan.

Peter holds a Bachelor degree in Global Logistics and Forwarding from Deutsche Verkehrsschule in Breman, Germany.

Stephen Laaper is a Digital Supply Networks leader in Deloitte Consulting’s Strategy & Operations practice. He brings a unique mix of industry, consulting, and technology experience with a broad range of clients across the life sciences, automotive, and consumer products sectors. He serves clients in their journey to advance their supply chain and manufacturing capabilities through digital technologies, including advanced analytics, advanced manufacturing, partner collaboration, and Industrial applications of the Internet of Things (IoT).

Stephen has a passion for advanced manufacturing techniques, connecting the logical and physical world, and leveraging digital opportunities across the enterprise to connect companies to their customers and patients. He graduated from Northwestern University - Kellogg School of Management.

Michael Ventura joined TraceLink following a 30-year career as the former serialization and security lead for GlaxoSmithKline (GSK), including nine years as an active GS1 Global and GS1 US member, where he currently serves as an elected member of the GS1 US Executive Leadership Team and co-chair of the Traceability Team. While at GSK, he led the company’s patient safety and fraud prevention efforts and provided guidance on implementing effective solutions for EMR development, SMS patient authentication, point-of-dispense authentication, and full traceability pilots. In his current role with TraceLink, Ventura leads strategic discussions with pharmaceutical companies that face significant infrastructure and operational challenges in meeting global track and trace compliance deadlines, and provides practical insight to manufacturers that are working to put successful serialization strategies in place over the next several years.

Hussain has more than 20 years of experience of running supply chains, manufacturing plants, sales & marketing as well as consulting. Hussain has had great success in leading numerous initiatives including global value chain transformations, developing emerging sales models in med tech, redesigning contract manufacturing models, control tower rollouts and ERP deployments. Hussain’s previous roles have included managing vice president at Gartner and AMR Research and director at Trinity Pharma Solutions and he has been selected by Pharma Voice as one of the 100 most influential and inspiring individuals in life sciences.

Chandra is Supply Chain / ERP Thought Leader for Biogen and has been playing a key role in Supply Chain Transformation and ERP Roadmap at Biogen. He has over 20 years of experience in supply chain, & Manufacturing across various industries. He also brings in more than 15 years of experience managing sales, global engagements and solution engineering with focus in the area of Oracle ERP & Supply Chain. He has worked with several global organizations in the past to assist them in their supply chain transformations especially in the area of Global Supply Chain Planning and S & OP. He holds a Bachelor of Technology in Mechanical Engineering from IIT Bombay.

Alex is a Senior Leader in Deloitte Consulting’s Life Sciences Supply Chain Strategy & Operations practice.  He has more than 20 years of industry experience with biopharmaceutical and specialty pharma companies in areas including global manufacturing and end-to-end supply chain. 

Alex’s experience includes a strong focus on operations strategy and helping companies with operational readiness to meet market demand across traditional and emerging markets. He has led initiatives to help companies establish and optimize platforms for sustainable growth in technical operations and product supply, drive operational performance, and reduce operating expenses with a focus on capacity, utilization, and throughput.  Alex’s work on strategic initiatives has included leading functional organizations through network and site operations optimization, network optimization for investments/ divestments, supply chain segmentation, and operating model (re)design and implementation across global networks.

Alex holds an MBA in Strategy & Finance from the Mendoza School of Business at the University of Notre Dame and a BA from the University of California, Los Angeles.

Jen  is Vice President, Global Planning with global responsibility for supply and demand planning, S&OP, and inventory optimization for Allergan.  Allergan is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand, OTC and biosimilar products with over $20B in revenue.  Jen has been involved in integration of Allergan, Forest, Warner Chicott, and Actavis in her three years with the company.  Prior to that, , Jen was with Johnson & Johnson for 10 years in Consumer Products and Pharmaceutical sectors in both NJ and the Bay Area.  She had a variety of leadership roles including commercialization of an innovative combination drug device, new product project management, and supply chain planning.

Jen has a BSE in Operations Research from Princeton University and an MBA from Harvard University. 

Lisa Baker, Supply Chain Director, is Amgen’s Controlled Environment Logistics business process owner.  Lisa has more than 20 years of experience in the biotechnology field with a focus on Operations, including Manufacturing, Quality Assurance, and Supply Chain.  In early 2015, Lisa joined the Global Logistics team and has been responsible for implementing the redesign of the Controlled Environment Logistics processes to significantly improve Amgen’s cold chain execution.  In her current role, she leads the Amgen’s global cold chain network that is focused on improvement and sustainability of Controlled Environment Logistics business processes.

Allen brings nearly 30 years of pharma and health sciences supply chain experience to FusionOps. He joined FusionOps from Pfizer, Inc., where as VP of Network Supply Planning, he was responsible for production planning, issue identification and mitigation via S&OP processes, and global inventory. Prior to Pfizer, he was AVP of Supply Chain for Wyeth Pharmaceuticals, Director of Supply Chain for Baxter Bioscience, and managed a medical device joint venture in Yugoslavia. Allen received his degree in Microbiology from the University of Maryland and did graduate work and research in immunology at Johns Hopkins University.

Stephen Meyer is a Research Director in Gartner's Supply Chain group. Mr. Meyer joined Gartner with 19 years of experience in global supply chain management roles in the life sciences, chemical and retail industries. In his previous positions, he has had both functional and leadership responsibility for sourcing, procurement, planning/forecasting, operational excellence, warehousing, logistics, and transportation.

Prior to joining Gartner, Mr. Meyer worked for AngioDynamics, a medical device manufacturer headquartered in Albany, New York. At AngioDynamics, he led the Global Supply Chain department and was responsible for the purchasing, planning, warehouse and distribution teams. Mr. Meyer has also held key roles in the supply chain organizations at Amazon, AMRI, C. R. Bard and GE. He has significant experience with ERP implementation and configuration, sales and operations planning, statistical forecasting and its application to production/buying models, and service analytics.

Stefan Hockenberger, author of the book ‘Track & Trace with Sap Solutions’, is a member of the board at Movilitas Consulting and leads the global Track & Trace practice with 45 dedicated SAP Track & Trace consultants around the globe. Prior to his current position with Movilitas, Stefan had been responsible for Marketing and the business unit SAP Track & Trace at Movilitas Consulting AG, the world market leader in terms of experience in the area of SAP Track & Trace with projects in 11 out of the top 15 pharmaceutical companies. From 2002 to 2009 Stefan worked as Solution Sales Executive at SAP Germany AG & Co. KG and had the overall Pre-Sales responsibility for “SAP Track & Trace” within all industries in Germany, Austria and Switzerland. Stefan holds a Master of Business Administration from the “Berufsakademie Mannheim”, University of Cooperative Education.

Todd leads the Healthcare-Life Sciences practice for FICO, a global leader of decision management software, predictive analytics and decision applications. Todd is a dynamic marketer with over twenty years of experience creating, launching and managing pharmaceutical brands.  He is most excited by opportunities to bring new technologies and deep client experience together to optimize revenue, customer engagement and loyalty. 

Zahir develops customer focused solutions within FICO’s Decision Management Suite. With over 20 years of business and IT operations experience, he brings thought leadership to the development of advanced analytics solutions across analytical domains and industry verticals. He also specializes in change management associated with deploying process disruptive technologies. Before coming to FICO, Zahir was Director of Advanced Planning and Decision Sciences at Schneider, a leading provider of truckload, logistics and intermodal services. His team specialized in the application of advanced analytical techniques for operational, tactical and strategic decision support across the enterprise.

Zahir is a Certified Analytics Professional through INFORMS. He is actively involved with INFORMS serving as President of the Analytics Section, and has served on the advisory council for the Business Analytics Conference for the last nine years. He is acknowledged in the books Competing on Analytics by Davenport and Harris, and The New Know by Thornton May. Zahir has a BS in Computer Engineering, an MS in Industrial Engineering, and an MS in System Dynamics.